首页> 外文期刊>The Internet Journal of Nephrology >Towards the Psychosocial Treatment of Depressed Patients on Dialysis
【24h】

Towards the Psychosocial Treatment of Depressed Patients on Dialysis

机译:透析抑郁症患者的社会心理治疗

获取原文
           

摘要

There is a growing literature on the bidirectional relationship between depression and various medical illnesses but depression in end stage renal disease has been understudied. In this paper we review the literature on the relationship between end stage renal disease and depression and then present a framework for the cognitive behavioral treatment of the depressed patient on dialysis. Case material from three different clients is then used to demonstrate some of the representative issues that arise in treatment in this population. This paper also explores the utility of using a subset of the Beck Depression Inventory [1] that focus on the cognitive factors of depression as a more sensitive measure for depression within the medically ill. Implications of the paper as well as indications for future research are discussed. Introduction There are a variety of biological, psychological and social pathways that have been suggested between medical illness and depression [2], but there has also been increasing evidence that this relationship is bidirectional [3]. There is a growing literature in the fields of cardiovascular health [4], cancer [5], diabetes [6], and stroke [7], but depression in end stage renal disease has been understudied [8]. End Stage Renal Disease End stage renal disease (ESRD) is defined as the point when kidney function is at 10% of baseline [9]. According to the most recent estimates [10], ESRD affects some 20 million Americans, and 20 million more are at risk for developing chronic kidney disease. The leading causes of ESRD are diabetes, which accounts for 44% of new cases, and uncontrolled high blood pressure, which accounts for 35% of new cases. The treatment options for ESRD fall into two broad categories: hemodialysis or kidney transplantation. Transplantation is a complex process that often involves waiting for years for an appropriate match. Subsequent to the transplantation there are often medical complications and transplanted kidneys remain viable only for an average of 5 years [11]. Dialysis is a medical procedure designed to remove wastes, toxins and fluids from the blood when the kidneys have failed. Living on dialysis is a perpetual challenge, due to its demanding schedule of treatment, dietary restrictions and changes in function (See [12] for a patient's description). Life on dialysis also shares similarities with other chronic disorders in that there are threats to autonomy, depression, burden of illness, and change in functional status [13]. The life expectancy of dialysis patients is one- third to one- sixth of the normal US population [10]. Depression in ESRD Despite the medical severity of kidney failure, the obvious challenges that life on dialysis poses, and the extraordinary medical cost of treatment, relatively little is known about the mental health of this population. The consensus in the literature is that depression is a common comorbid mental disorder for a subgroup of patients with ESRD [14,15,16,17,18,19]. However, the actual reported prevalence rates vary widely from 20% [17] to 44% [19]. Kimmel [14] points out that this wide variation can be attributed primarily to two factors. First, operational definitions of depression and measurement techniques are quite varied. Some studies [17] use clinical diagnosis of depression, or Likert-scale responses to a single question about depression, while others [19] use the Beck Depression Inventory (BDI) with a cutoff of 15. Second, and perhaps more importantly, there is an overlap of symptoms of depression with symptoms of chronic medical illness [14,16]. For example, there is an overlap of depressive and uremic symptoms. The depressive symptoms of psychomotor agitation or retardation, decreased appetite or weight change, sleep disturbance and aches and pains are also often difficult to distinguish from the uremic symptoms of encephalopathy, anorexia/edema, sleep apnea/anemia/volume overload/congestive heart failure and neuropathy/arthro
机译:关于抑郁与各种医学疾病之间的双向关系的文献越来越多,但对终末期肾脏疾病的抑郁的研究仍很不足。在本文中,我们回顾了有关终末期肾脏疾病与抑郁之间关系的文献,然后提出了针对抑郁患者进行透析的认知行为治疗的框架。然后使用来自三个不同客户的案例材料来证明在该人群的治疗中出现的一些代表性问题。本文还探讨了使用贝克抑郁量表的一个子集[1]的实用性,该量表着重于抑郁的认知因素,将其作为对医学疾病患者抑郁症的更敏感衡量指标。讨论了本文的含义以及未来研究的迹象。引言在医学疾病和抑郁症之间已提出了多种生物学,心理和社会途径[2],但也越来越多的证据表明这种关系是双向的[3]。在心血管健康[4],癌症[5],糖尿病[6]和中风[7]领域中,有越来越多的文献,但是对终末期肾脏疾病的抑郁症的研究仍在研究中[8]。终末期肾脏疾病终末期肾脏疾病(ESRD)定义为肾功能达到基线的10%的时间点[9]。根据最新的估计[10],ESRD影响了大约2000万美国人,另有2千万人处于发展慢性肾脏病的危险中。 ESRD的主要原因是糖尿病(占新病例的44%)和不受控制的高血压(占新病例的35%)。 ESRD的治疗选择可分为两大类:血液透析或肾脏移植。移植是一个复杂的过程,通常需要等待数年才能进行适当的比赛。移植后通常会发生医疗并发症,并且移植的肾脏平均只能存活5年[11]。透析是一种医疗程序,旨在在肾脏衰竭时从血液中清除废物,毒素和体液。透析生活是一项永恒的挑战,因为它要求严格的治疗方案,饮食限制和功能改变(有关患者的描述,请参见[12])。透析生活也与其他慢性疾病有相似之处,因为它们会威胁自治,抑郁,疾病负担和功能状态的改变[13]。透析患者的预期寿命是美国正常人口的三分之一至六分之一[10]。 ESRD的抑郁症尽管肾脏衰竭的医疗严重程度,透析生活带来的明显挑战以及极高的医疗成本,对该人群的心理健康知之甚少。文献中的共识是,抑郁症是ESRD患者亚组的一种常见的共病性精神障碍[14,15,16,17,18,19]。但是,实际报告的患病率从20%[17]到44%[19]不等。 Kimmel [14]指出,这种广泛的差异主要归因于两个因素。首先,抑郁症和测量技术的操作定义千差万别。一些研究[17]使用抑郁症的临床诊断,或对一个关于抑郁症的单个问题进行李克特量表的回答,而另一些研究[19]使用贝克抑郁量表(BDI)的截止值为15。第二,也许更重要的是,那里是抑郁症状与慢性内科疾病症状的重叠[14,16]。例如,抑郁症和尿毒症症状重叠。精神运动性躁动或发育迟缓的抑郁症状,食欲降低或体重减轻,睡眠障碍以及疼痛和疼痛通常也很难与脑病,尿毒症/水肿,睡眠呼吸暂停/贫血/容量超负荷/充血性心力衰竭的尿毒症症状区分开神经病/关节炎

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号